Rocket One (RKTO) Exchange Rate Effect (2020 - 2026)
Rocket One's (RKTO) quarterly Exchange Rate Effect came in at -$1068.0 in Q2 2026, down 130.71% year-over-year from $3478.0 in Q2 2025, and down 167.68% quarter-over-quarter from $1578.0 in Q1 2026.
Powered by 
Analysis
Rocket One (RKTO) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Rocket One has disclosed Exchange Rate Effect across 7 years of filings, most recently posting -$1068.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 130.71% year-over-year to -$1068.0; the TTM figure through Jun 2026 stood at -$703.0 (up 93.66% YoY), while the FY2025 annual figure was $1768.0, up 109.72% from the prior year.
- Exchange Rate Effect came in at -$1068.0 for Q2 2026 at Rocket One, down from $1578.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $535509.0 in Q4 2023 to a low of -$485943.0 in Q3 2023.
- Average Exchange Rate Effect over 5 years is -$1779.4, with a median of -$756.5 recorded in 2025.
- The largest YoY upside for Exchange Rate Effect was 524908.82% in 2023 against a maximum downside of 12952.46% in 2023.
- Over 5 years, Exchange Rate Effect stood at $102.0 in 2022, then soared by 524908.82% to $535509.0 in 2023, then sank by 103.09% to -$16553.0 in 2024, then jumped by 98.81% to -$197.0 in 2025, then plunged by 442.13% to -$1068.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$1068.0 in Q2 2026, $1578.0 in Q1 2026, and -$197.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 315,000.00 |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | -1,068.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,068.00 |
| Mar 31, 2026 | 1,578.00 |
| Dec 31, 2025 | -197.00 |
| Sep 30, 2025 | -1,016.00 |
| Jun 30, 2025 | 3,478.00 |
| Mar 31, 2025 | -497.00 |
| Dec 31, 2024 | -16,553.00 |
| Sep 30, 2024 | 2,490.00 |
| Jun 30, 2024 | 1,634.00 |
| Mar 31, 2024 | -5,768.00 |
| Dec 31, 2023 | 535,509.00 |
| Sep 30, 2023 | -485,943.00 |
| Jun 30, 2023 | -49,883.00 |
| Mar 31, 2023 | -6,201.00 |
| Dec 31, 2022 | 102.00 |
| Sep 30, 2022 | -3,723.00 |
| Jun 30, 2022 | -9,973.00 |
| Mar 31, 2022 | 4,001.00 |
| Dec 31, 2021 | 12,568.00 |
| Sep 30, 2021 | -24,025.00 |